From 2 to 4 October, 2015 in Rome the greatest experts of ophthalmology in the world will discuss the role of diabetes, the role of aging, the development of new methods of prevention and diagnosis, and future diagnostic and surgical techniques of eye diseases.
Share
The appointment is for the IX International Meeting for the Study and Research in Ophthalmology organized dall’IRCCS Foundation GB Bietti for the Study and Research in Ophthalmology: an event that has received the patronage of the President of the Republic
, sponsored by the Ministry of Health, the Lazio Region and the City of Rome, and is implemented with the support of Rome Foundation.
For three days, leading experts and researchers from around the world will discuss the issues concerning the diagnosis and treatment of eye diseases of social impact, focusing on new treatments, the most innovative research and surgery. The role of diabetes (first cause of legal blindness in Italian) on eye health, the role of aging, the clinical development of new methods of prevention and early diagnosis and evaluation of the most recent is that of the future of diagnostic and surgical techniques eye diseases.
“The last part of the twentieth century – he said Prof. Mario Kin, President of the Foundation GB Bietti and the International Congress – recorded in ophthalmology face a major commitment to the improvement and creation of new surgical techniques
. These have allowed, on the one hand, to be able to maintain visual function useful to many eyes previously intended to blindness, as is the case for retinal surgery and, to another side, to be able to optimize the visual rehabilitation post-operative as well as occurred for cataract surgery.
The pharmacological research and the technological – says Professor Kin – have offered in recent years new perspectives of care directed at diseases until now considered incurable. Evaluation of the prospects offered by new drugs and gene and molecular therapies for the treatment of retinal diseases represent some of the main new features that will be discussed “.
Biotechnologies developed over the last decade in ophthalmology are having a considerable impact on the lives of millions of people with visual impairment. New therapies have changed the prognosis of many diseases, both
frequent as the related macular degeneration and glaucoma, or rare, such as inherited retinal dystrophies.
The clinical use of new biomarkers based on adaptive optics technology for ultra-early diagnosis of retinal diseases represent in the coming years one of the most effective means to prevent the loss of vision caused by the disease more frequently due of visual impairment, including diabetic retinopathy.
The use of new therapies based on stem cells and gene therapy is showing the first successes therapeutic for the treatment of serious eye diseases, such as deficiency of limbal stem cells and retinal dystrophies.
During the Congress will receive the “Gold Medal of the Foundation Bietti”, a recognition to those who research brought a contribution deemed significant for the community ophthalmology.
This year the Gold Medal of the IRCCS Foundation Bietti be attributed to Prof. Lamberto Maffei, a genius of the research, who has never been tempted to leave the country.
Professor Lamberto Maffei is currently Vice President of the National Academy of the Lincei and was for many years director of the Institute of Neurophysiology at the CNR in Pisa. His scientific publications, journals of primary importance as Science and Nature, have provided a major contribution in the understanding of the physiology and pathology of the nervous system view.
No comments:
Post a Comment